학술논문
Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies
Document Type
Article
Author
Source
In Blood 21 March 2024 143(12):1124-1138
Subject
Language
ISSN
0006-4971